<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>UNAAGI: Atom-Level Diffusion for Generating Non-Canonical Amino Acid Substitutions - Health AI Hub</title>
    <meta name="description" content="UNAAGI is a novel diffusion-based generative model addressing the limitation of current inverse folding methods that are restricted to designing natural amino a">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>UNAAGI: Atom-Level Diffusion for Generating Non-Canonical Amino Acid Substitutions</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.10515v1" target="_blank">2512.10515v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-11
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Han Tang, Wouter Boomsma
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.BM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.10515v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.10515v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">UNAAGI is a novel diffusion-based generative model addressing the limitation of current inverse folding methods that are restricted to designing natural amino acid (NAA) substitutions. By modeling protein side chains at the atomic level, UNAAGI enables the exploration and generation of both NAAs and non-canonical amino acids (NCAAs), demonstrating substantially improved performance for NCAA substitutions and suggesting a unified methodological foundation for protein engineering and structure-based drug design.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for advancing protein engineering and drug discovery by enabling the rational design of proteins incorporating diverse non-canonical amino acids, potentially leading to novel therapeutics with enhanced stability, function, or target specificity.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>UNAAGI is a diffusion-based generative AI model designed to predict and generate amino acid substitutions, including non-canonical ones, from atomic-level protein structures. This AI application is crucial for: 1) accelerating the design of novel proteins with desired therapeutic or diagnostic functions; 2) improving the prediction of mutational effects, which is vital for understanding genetic diseases and drug resistance; and 3) aiding structure-based drug design by enabling a more comprehensive exploration of protein-ligand interactions and protein modifications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Current inverse folding models for amino acid substitution are constrained to designing only natural amino acids (NAAs).</li>
                    
                    <li>Non-canonical amino acids (NCAAs) offer greater chemical diversity and are important for *in-vivo* protein engineering but remain largely inaccessible to existing variant effect prediction methods.</li>
                    
                    <li>UNAAGI is introduced as a diffusion-based generative model designed to reconstruct residue identities from atomic-level protein structures using an E(3)-equivariant framework.</li>
                    
                    <li>A key methodological innovation is modeling side chains in full atomic detail, rather than as discrete tokens, which enables the exploration and generation of both NAAs and NCAAs within a unified paradigm.</li>
                    
                    <li>The method was evaluated on experimentally benchmarked mutation effect datasets, showing substantially improved performance for NCAA substitutions compared to current state-of-the-art approaches.</li>
                    
                    <li>The research suggests a shared methodological foundation between the fields of protein engineering and structure-based drug design.</li>
                    
                    <li>This work opens the door for developing a unified training framework that could integrate protein engineering and structure-based drug discovery efforts.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>UNAAGI utilizes a diffusion-based generative modeling approach within an E(3)-equivariant framework. It reconstructs residue identities directly from atomic-level protein structures. Crucially, it models side chains in full atomic detail, allowing for the generation of both natural and non-canonical amino acids within a single, unified generative paradigm.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>UNAAGI achieves substantially improved performance on non-canonical amino acid (NCAA) substitutions compared to current state-of-the-art methods, as demonstrated on experimentally benchmarked mutation effect datasets. Furthermore, the findings suggest a shared methodological foundation between protein engineering and structure-based drug design.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology could significantly accelerate the design and optimization of therapeutic proteins, enzymes, and biomaterials with novel functions, improved stability, or enhanced specificity by leveraging the expanded chemical space of NCAAs. It has the potential to facilitate the development of next-generation biologics and targeted drug candidates, leading to more effective treatments and diagnostics.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The study suggests the potential for developing a unified training framework that can span both protein engineering and structure-based drug design, opening new avenues for integrated research in these domains.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Protein Engineering</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Biotechnology</span>
                    
                    <span class="tag">Therapeutic Protein Development</span>
                    
                    <span class="tag">Synthetic Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Non-canonical amino acids</span>
                    
                    <span class="tag tag-keyword">Protein engineering</span>
                    
                    <span class="tag tag-keyword">Diffusion models</span>
                    
                    <span class="tag tag-keyword">Generative models</span>
                    
                    <span class="tag tag-keyword">Amino acid substitution</span>
                    
                    <span class="tag tag-keyword">Inverse folding</span>
                    
                    <span class="tag tag-keyword">Structure-based drug design</span>
                    
                    <span class="tag tag-keyword">E(3)-equivariant</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Proposing beneficial amino acid substitutions, whether for mutational effect prediction or protein engineering, remains a central challenge in structural biology. Recent inverse folding models, trained to reconstruct sequences from structure, have had considerable impact in identifying functional mutations. However, current approaches are constrained to designing sequences composed exclusively of natural amino acids (NAAs). The larger set of non-canonical amino acids (NCAAs), which offer greater chemical diversity, and are frequently used in in-vivo protein engineering, remain largely inaccessible for current variant effect prediction methods.
  To address this gap, we introduce \textbf{UNAAGI}, a diffusion-based generative model that reconstructs residue identities from atomic-level structure using an E(3)-equivariant framework. By modeling side chains in full atomic detail rather than as discrete tokens, UNAAGI enables the exploration of both canonical and non-canonical amino acid substitutions within a unified generative paradigm. We evaluate our method on experimentally benchmarked mutation effect datasets and demonstrate that it achieves substantially improved performance on NCAA substitutions compared to the current state-of-the-art. Furthermore, our results suggest a shared methodological foundation between protein engineering and structure-based drug design, opening the door for a unified training framework across these domains.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>